Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamal Meghrous

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Virological Methods|September 25, 2002
Quantitation of baculovirus particles by flow cytometryChun Fang Shen, Jamal Meghrous, Amine Kamen
Journal of Virological Methods|December 21, 2005
Analysis of baculovirus aggregates using flow cytometryHasnaa Jorio, Rosa Tran, Jamal Meghrous, et al.
Journal of Virological Methods|February 20, 2007
High yield purification of functional baculovirus vectors by size exclusion chromatographyJulia Transfiguracion, Hasnaa Jorio, Jamal Meghrous, et al.
Vaccine|November 3, 2009
Development of a simple and high-yielding fed-batch process for the production of influenza vaccinesJamal Meghrous, Wafaa Mahmoud, Danielle Jacob, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2007
Virus-like particle and viral vector production using the baculovirus expression vector system/insect cell system: adeno-associated virus-based productsMarc G Aucoin, Danielle Jacob, Parminder Singh Chahal, et al.
Biotechnology Progress|May 21, 2005
Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactorJamal Meghrous, Marc G Aucoin, Danielle Jacob, et al.
Biotechnology and Bioengineering|May 7, 2015
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cellsJamal Meghrous, Nikolai Khramtsov, Barry C Buckland, et al.
Vaccine|August 19, 2014
Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing processBarry Buckland, Robert Boulanger, Mireli Fino, et al.
BMC Biotechnology|December 26, 2014
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossKathleen M Holtz, Pamela S Robinson, Erin E Matthews, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Virological Methods|September 25, 2002
Quantitation of baculovirus particles by flow cytometryChun Fang Shen, Jamal Meghrous, Amine Kamen
Journal of Virological Methods|December 21, 2005
Analysis of baculovirus aggregates using flow cytometryHasnaa Jorio, Rosa Tran, Jamal Meghrous, et al.
Journal of Virological Methods|February 20, 2007
High yield purification of functional baculovirus vectors by size exclusion chromatographyJulia Transfiguracion, Hasnaa Jorio, Jamal Meghrous, et al.
Vaccine|November 3, 2009
Development of a simple and high-yielding fed-batch process for the production of influenza vaccinesJamal Meghrous, Wafaa Mahmoud, Danielle Jacob, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2007
Virus-like particle and viral vector production using the baculovirus expression vector system/insect cell system: adeno-associated virus-based productsMarc G Aucoin, Danielle Jacob, Parminder Singh Chahal, et al.
Biotechnology Progress|May 21, 2005
Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactorJamal Meghrous, Marc G Aucoin, Danielle Jacob, et al.
Biotechnology and Bioengineering|May 7, 2015
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cellsJamal Meghrous, Nikolai Khramtsov, Barry C Buckland, et al.
Vaccine|August 19, 2014
Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing processBarry Buckland, Robert Boulanger, Mireli Fino, et al.
BMC Biotechnology|December 26, 2014
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossKathleen M Holtz, Pamela S Robinson, Erin E Matthews, et al.
Pageof 1